Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 20 (RPL5P20) is a processed pseudogene located in the human genome that shares sequence homology with the functional ribosomal protein L5 gene (RPL5). Unlike the parent RPL5 gene, which encodes a critical structural component of the 60S ribosomal subunit involved in protein synthesis and cellular homeostasis, RPL5P20 does not produce a functional protein. Pseudogenes such as RPL5P20 are typically transcriptionally silent and do not participate in physiological or pathological processes, nor are they recognized as therapeutic drug targets. The functional RPL5 gene plays important roles in ribosome assembly, p53 regulation, and tumor suppression, but these functions are not attributable to its pseudogenes, including RPL5P20.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 20 (RPL5P20).